Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700034850

Trial Profile

Clinical Trials Insight: 700034850

Phase of Trial: Phase I

Latest Information Update: 24 Oct 2009

At a glance

  • Drugs PSN 602 (Primary)
  • Indications Obesity
  • Focus Adverse reactions
  • Sponsors OSI Pharmaceuticals
  • Most Recent Events

    • 24 Oct 2009 Results in a cohort of 38 patients presented at the 2009 Annual Meeting of the North American Association for the Study of Obesity (NAASO 2009).
    • 12 May 2009 According to an OSI Pharmaceuticals media release, results of this trial will be presented at a scientific meeting in the second half of 2009. Results also reported in this media release.
    • 12 May 2009 Status changed from recruiting to completed, according to an OSI Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top